NorthWest Biotherapeutics Inc (NWBO)

[Dan88]

If you have time to go through this example: http://www.cathlabdigest.com/articles/FAME-II-Stopped-Enrollment-Early-More-Events-Medical-Arm-What-Does-It-Mean-PCI

you would understand what has been really happening behind the scene that is [my speculation of course but with some logic and supports]I reaffirm that DMC has recommend the P3 DCVax-L trial stopped for efficacy so the enrolment of the patients should be stopped due to ethics reason;

Northwest Biotherapeutics Inc. has thus "only" elected to "temporarily stop new patient screening" pending FDA blessing (AA) with materials asked by and submitted to FDA.

Only after the blessing of FDA, can the company announce stop of enrolment, and continue [has been continuing] to monitoring the existing patients to the final events [it may be a full approval or the company may be asked to do a P4 confirmation study].

There are also other possibilities as I have said before but definitely not anything to do with safety.